Neissena gonorrhoeae causes both localized uncomplicated infections at mucosal surfaces and more invasive forms of disease including pelvic inflammatory disease and disseminated gonococcal infection. The ability of gonococci to evade the antimicrobial action of mediators of innate host defense at mucosal surfaces or in the bloodstream is of likely importance in its ability to survive eariy during infection. In this project we will focus on determining whether mechanisms of gonococcal resistance to antimicrobial agents of innate host defense impact infectivity and/or in vivo fitness.
In Specific Aim 1 we will test the role of the MtrC-MtrD MtrE efflux pump in determining the ability of gonococci to Infect the male urethra. To our knowledge, this will be the first test of the importance of any microbial efflux pump in promoting an infection in humans. The MtrC-MtrD-MtrE efflux pump endows gonococci with a mechanism to export hydrophobic antibiotics and host-derived antimicrobials (antimicrobial peptides, bile salts and progesterone) that bathe mucosal surfaces. The proteins that fomn the pump are encoded by the mtrCDE operon, which is transcriptionally regulated by cis- and frans-acting regulatory control processes. These regulatory systems modulate levels of gonococcal fitness in a murine model of lower genital tract infection and we will now test if they also modulate in vivo fitness in humans.
In Specific Aim 2 we will determine whether mutations that alter lipooligosaccharide structure and are known to result in changes in gonococcal susceptibility to the killing action of normal human serum or cationic antimicrobial peptides impact gonococcal infectivity and/or in vivo fitness. We hypothesize that mediators of the innate host defense system function at the genital mucosal surface as antibiotics and as a consequence of their antimicrobial action against gonococci, resistant variants ultimately emerge and these have a competitive advantage during infection. Accordingly, in Specific Aim 3 we will isolate laboratory-derived mutants of gonococci with altered levels of susceptibility to host-derived antimicrobials and test if such strains have increased or decreased fitness in vivo. The results will provide important insights regarding the ability of gonococci to adapt to the in vivo environment.

Public Health Relevance

The goal of this project is to understand how the strict human pathogen Neisseria gonorrhoeae resists the natural host defenses that normally function during infection. The information gained from this investigation will help in the development of an effective vaccine to prevent gonorrhea, which remains a worid-wide public health problem.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-MMT-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Chapel Hill
United States
Zip Code
Rice, Cara E; Gallo, Maria F; Hobbs, Marcia M et al. (2014) Prostate-specific antigen is unlikely to be a suitable biomarker of semen exposure from recent unprotected receptive anal intercourse in men who have sex with men. Sex Transm Dis 41:377-9
Packiam, Mathanraj; Yedery, Roshan D; Begum, Afrin A et al. (2014) Phosphoethanolamine decoration of Neisseria gonorrhoeae lipid A plays a dual immunostimulatory and protective role during experimental genital tract infection. Infect Immun 82:2170-9
Jerse, Ann E; Bash, Margaret C; Russell, Michael W (2014) Vaccines against gonorrhea: current status and future challenges. Vaccine 32:1579-87
VĂ©lez Acevedo, Rosuany N; Ronpirin, Chalinee; Kandler, Justin L et al. (2014) Identification of regulatory elements that control expression of the tbpBA operon in Neisseria gonorrhoeae. J Bacteriol 196:2762-74
Golparian, Daniel; Shafer, William M; Ohnishi, Makoto et al. (2014) Importance of multidrug efflux pumps in the antimicrobial resistance property of clinical multidrug-resistant isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 58:3556-9
Fusco, William G; Choudhary, Neelima R; Routh, Patty A et al. (2014) The Haemophilus ducreyi trimeric autotransporter adhesin DsrA protects against an experimental infection in the swine model of chancroid. Vaccine 32:3752-8
Zhou, Xiyou; Gao, Xi; Broglie, Peter M et al. (2014) Hexa-acylated lipid A is required for host inflammatory response to Neisseria gonorrhoeae in experimental gonorrhea. Infect Immun 82:184-92
Kandler, Justin L; Joseph, Sandeep J; Balthazar, Jacqueline T et al. (2014) Phase-variable expression of lptA modulates the resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides. Antimicrob Agents Chemother 58:4230-3
Unemo, Magnus; Shafer, William M (2014) Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev 27:587-613
Noinaj, Nicholas; Cornelissen, Cynthia Nau; Buchanan, Susan K (2013) Structural insight into the lactoferrin receptors from pathogenic Neisseria. J Struct Biol 184:83-92

Showing the most recent 10 out of 86 publications